Annals of Emergency Medicine
Volume 49, Issue 6 , Pages 806-813, June 2007

Sodium Thiosulfate or Hydroxocobalamin for the Empiric Treatment of Cyanide Poisoning?

  • Alan H. Hall, MD

      Affiliations

    • Toxicology Consulting and Medical Translating Services, Inc., Elk Mountain, WY
    • Department of Preventive Medicine and Biometrics, the University of Colorado Health Sciences Center, Denver, CO
    • Corresponding Author InformationAddress for correspondence: Alan H. Hall, MD, TCMTS, Inc., PO Box 184, Mile 5.0 Pass Creek Road, Elk Mountain, WY 82324; 307-348-7371, fax 307-348-7372
    • ,
  • Richard Dart, MD, PhD

      Affiliations

    • Rocky Mountain Poison and Drug Center, Denver Health, Denver, CO
    • Department of Surgery [Emergency Medicine], the University of Colorado Health Sciences Center, Denver, CO
    • Corresponding Author InformationAddress for reprints: Richard Hart, MD, PhD, Rocky Mountain Poison and Drug Center, 770 Bannock Street, MC 0180, Denver, CO 80204.
    • ,
  • Gregory Bogdan, PhD

      Affiliations

    • Rocky Mountain Poison and Drug Center, Denver Health, Denver, CO
    • Department of Pharmaceutical Sciences, the University of Colorado Health Sciences Center, Denver, CO.

Received 13 April 2006; received in revised form 31 August 2006; accepted 25 September 2006. published online 14 November 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supervising editor: Donald M. Yealy, MDFunding and support: Dr. Hall’s work on this article was supported in part by EMD Pharmaceuticals, Inc., Durham, NC, an affiliate of Merck KGaA and the US developer of the cyanide antidote hydroxocobalamin (Cyanokit). Drs. Hall, Dart, and Bogdan are members of the Cyanokit Advisory Board of EMD Pharmaceuticals, Inc.Publication dates: Available online November 13, 2006.

PII: S0196-0644(06)02276-1

doi:10.1016/j.annemergmed.2006.09.021

Refers to article:

  • Is Hydroxocobalamin Safe and Effective for Smoke Inhalation? Searching for Guidance in the Haze

    Andrew R. Erdman
    Annals of Emergency Medicine June 2007 (Vol. 49, Issue 6, Pages 814-816)

Annals of Emergency Medicine
Volume 49, Issue 6 , Pages 806-813, June 2007

Article Tools